(Many people use Ozempic off label for weight loss, though it is not FDA-approved for such.) These medications seem to promote weight loss through two mechanisms that, again, mimic the action of endogenous GLP-1: They delay gastric emptying: The sensation of fullness caused by slower gastric emptying can prompt people to eat less, thus helping them lose weight over time
So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
If you are unsure whether your medication is still good, checking semaglutide shelf life guidelines or tirzepatide shelf life information can help you make an informed decision
Graphical abstract Bu T, Sun Z, Pan Y, Deng X, Yuan G
Understanding these differences lets you make informed choices rather than random ones, and that matters when you are committing to a long-term weight loss protocol that may span months or even years
Answer : The major players in the GLP-1 market include Novo Nordisk, Eli Lilly and Company, Zealand Pharma, Structure Therapeutics, Amgen, Viking Therapeutics, Sanofi, AstraZeneca, and Hansoh Pharmaceutical Group Co
